Skip to content
OpenCapital
Earnings
Screener
Charts
Portfolio
Pricing
Connect your AI
Get started
Toggle navigation menu
LBR
LBRX
LBRX
Return on equity
Return on equity at other companies
Bristol-Myers Squibb
BMY
38.8%
+7.3pp
Alkermes
ALKS
9.4%
-16.1pp
Alto Neuroscience
ANRO
-38.9%
+0.9pp
Zevra Therapeutics, Inc.
ZVRA
100.7%
+60.3pp
Opko Health
OPK
-16.9%
-21.7pp
Acadia Pharmaceuticals
ACAD
37.3%
+0.1pp
Other financials
Income statement
See full
Net income
-$19.1M
-259%
EPS (diluted)
-$0.67
+95.5%
Balance sheet
See full
Cash & equivalents
$320.7M
—
Total debt
$3.5M
—
Total equity
$378.7M
+481%
Total assets
$393.5M
—
Cash flow
See full
Operating cash flow
-$23.3M
-187%
CapEx
$32.0K
+52.4%
Free cash flow
-$23.3M
-186%
Valuation
See full
Market cap
$874.06M
+159%
Enterprise value
$556.86M
—
Returns & leverage
See full
Debt / equity
0×
—
Current ratio
35.7×
—